Management ChangeJun 3, 2026, 05:26 PM
Celularity Appoints Rick Gonzalez as Chief Commercial Officer
AI Summary
Celularity Inc. announced the appointment of Rick Gonzalez as its new Chief Commercial Officer, effective May 29, 2026. Mr. Gonzalez will oversee global commercial strategy for the company's cenplacel-L and Lifebank platforms, reporting to CEO Robert J. Hariri. The company also provided a business update, highlighting its strategic focus on longevity and regenerative medicine, and mentioned the out-licensing of its biomaterials business to NexGel, Inc. for up to $30 million.
Key Highlights
- Celularity Inc. appointed Rick Gonzalez as Chief Commercial Officer, effective May 29, 2026.
- Mr. Gonzalez will report directly to Robert J. Hariri, Chairman and CEO.
- The company is advancing commercialization of cenplacel-L and its Lifebank cellular banking platform.
- Mr. Gonzalez brings over two decades of executive leadership experience in biotechnology and healthcare.
- Celularity also provided updates on its strategic focus on longevity and regenerative medicine.
- The company out-licensed its biomaterials business to NexGel, Inc. for up to $30 million.
Price Impact
More from CELU